Table 3.
Spearman’s rho analyses for consistency between sCTLA-4 and clinicopathological factors
| Clinicopathological factor | Correlation coefficient | P-value |
|---|---|---|
| Age | −0.083 | 0.325 |
| Gender | −0.088 | 0.302 |
| TNM stage | −0.405 | 0.000* |
| Therapy | −0.079 | 0.350 |
| Distant metastasis | −0.137 | 0.106 |
| Lymph node metastasis | −0.181 | 0.031* |
| WBC change | −0.161 | 0.056 |
| NEU change | 0.093 | 0.271 |
| LYM change | −0.032 | 0.710 |
| MON change | −0.107 | 0.205 |
Notes: Of all the clincopathological factors evaluated in this research, TNM stage and lymph node metastasis were correlated with sCTLA-4 level in whole patient group.
*
P<0.05.
Abbreviations: CI, confidence interval; HR, hazard ratio; LYM, lymphocyte; MON, monocyte; NEU, neutrophil; sCTLA-4, soluble cytotoxic T-lymphocyte antigen 4; TNM, tumor node metastasis; WBC, white blood cell.